This is a small, pre-announced sale by a non-executive officer and is unlikely to impact the stock price. Traders should monitor for actual execution of the sale and any pattern of additional insider selling, but this filing alone does not signal material concern.
Price Chart
Executive Summary
Daniel Bensen, an officer of Tyra Biosciences, filed a Form 144 to notify intent to sell up to 8,000 shares of common stock, valued at approximately $285,000, in two planned transactions on February 12 and March 12, 2026. This represents a routine, small-scale disposal of founder shares.
Key Facts
- Reporting person: Daniel Bensen, Officer
- Shares intended for sale: 8,000 shares (split across two planned sales)
- Total value of shares: $285,000 (average price ~$35.63/share)
- Shares are founder shares originally issued on August 28, 2018
- Planned sale dates: February 12, 2026, and March 12, 2026
- Broker: Merrill Lynch
Financial Impact
Approximately $285,000 in total value, representing a minor, pre-planned divestment.
Risk Factors
- Perception of insider selling could create minor downward pressure if market sentiment is fragile
- Failure to execute the sale as planned could signal changing sentiment, though not required
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-024915 |
| Document: 0001628280-26-024915-index.html | 0001628280-26-024915 |
| Document: 0001628280-26-024915.txt | 0001628280-26-024915 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | S-3ASR | $25.07 $25.65 | ▲ +2.31% | ▲ +2.21% | $20.50 (−18.21%) |
Sep 9, 2026 23d ago | 8-K | $22.01 $24.35 | ▲ +10.63% | ▲ +11.73% | $20.50 (−6.84%) |
Aug 4, 2026 8w ago | 424B5 | $25.71 $25.30 | ▲ +1.59% | ▲ +1.95% | $20.50 (+20.25%) |
Jun 26, 2026 13w ago | 144 | $32.11 $30.86 | ▲ +3.89% | ▲ +5.28% | $20.50 (+36.14%) |
May 13, 2026 20w ago | 8-K | $36.19 $33.78 | ▼ −6.66% | ▼ −5.50% | $20.50 (−43.34%) |
Apr 20, 2026 23w ago | 3 | $36.69 $35.06 | ▼ −4.44% | ▼ −5.53% | $20.50 (−44.11%) |
Apr 17, 2026 24w ago | DEFA14A | $35.56 $37.59 | ▲ +5.71% | ▲ +5.15% | $20.50 (−42.34%) |
Apr 17, 2026 24w ago | 8-K | $35.56 $37.59 | ▲ +5.71% | ▲ +5.15% | $20.50 (−42.34%) |
Apr 13, 2026 24w ago | 144 | $35.27 $36.69 | ▲ +4.03% | ▲ +2.63% | $20.50 (−41.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access